Colgate-Palmolive Co (NYSE:CL)
$ 94.53 0 (0%) Market Cap: 77.56 Bil Enterprise Value: 85.17 Bil PE Ratio: 29.91 PB Ratio: 337.61 GF Score: 87/100

Colgate-Palmolive Co at Barclays Global Consumer Staples Conference Transcript

Sep 04, 2019 / 11:30AM GMT
Release Date Price: $74.87 (+0.75%)
Lauren Rae Lieberman
Barclays Bank PLC, Research Division - MD & Senior Research Analyst

We're going to get started. We are happy to have Colgate-Palmolive kicking off day 2 of the conference, and in particular, the company's CEO, Noel Wallace, making his first time up on stage with us.

Colgate has posted a solid first half with better-than-expected gross margins, improvement in Latin America and better numbers in North America following the total relaunch. There are also interesting developments from the company's new more growth-oriented strategy, particularly from a channel standpoint and with M&A, particularly the prestige skincare category. We're excited to hear and see more as to how the company will look to "drive faster growth differently."

Noel, thanks so much for joining us.

Noel R. Wallace
Colgate-Palmolive Company - President, CEO & Director

Thanks, Lauren. Well, good morning, everyone. It's always great to be up in Boston. As we often do, I'm going to start off talking about our focused strategy as it's a strategy

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot